Factors Associated with High Rates of Recurrence of Amebic Liver Abscess (ALA) in North India.
暂无分享,去创建一个
[1] T. Banerjee,et al. Prevalence of cases of amebic liver abscess in a tertiary care centre in India: A study on risk factors, associated microflora and strain variation of Entamoeba histolytica , 2019, PloS one.
[2] C. Gilchrist,et al. Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia , 2017, The Journal of infectious diseases.
[3] P. V. van Genderen,et al. Recurrent amebic liver abscesses over a 16-year period: a case report , 2016, BMC Research Notes.
[4] R. Haque,et al. Role of the Gut Microbiota of Children in Diarrhea Due to the Protozoan Parasite Entamoeba histolytica , 2015, The Journal of infectious diseases.
[5] V. Dixit,et al. Efficacy of aspiration in amebic liver abscess. , 2015, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.
[6] T. Hannedouche,et al. First case of amebic liver abscess 22 years after the first occurrence , 2015, Parasite.
[7] Ajay Kumar,et al. Liver abscess: catheter drainage v/s needle aspiration , 2015 .
[8] Roman Thibeaux,et al. The parasite Entamoeba histolytica exploits the activities of human matrix metalloproteinases to invade colonic tissue , 2014, Nature Communications.
[9] R. Haque,et al. Amebic liver abscess in northern region of Bangladesh: sociodemographic determinants and clinical outcomes , 2014, BMC Research Notes.
[10] A. Mittal,et al. Recurrent amebic liver abscess , 2012, Indian Journal of Gastroenterology.
[11] Carolina Piña-Vázquez,et al. Host-Parasite Interaction: Parasite-Derived and -Induced Proteases That Degrade Human Extracellular Matrix , 2012, Journal of parasitology research.
[12] P. E. Van den Steen,et al. Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections. , 2012, Pharmacology & therapeutics.
[13] A. Verma,et al. Real-time analysis of gut flora in Entamoeba histolytica infected patients of Northern India , 2012, BMC Microbiology.
[14] S. Oka,et al. Amebiasis in HIV-1-Infected Japanese Men: Clinical Features and Response to Therapy , 2011, PLoS neglected tropical diseases.
[15] C. Cartwright,et al. Relapse of Intestinal and Hepatic Amebiasis After Treatment , 2011, Digestive Diseases and Sciences.
[16] J. Peipert,et al. Tuboovarian Abscesses: Is Size Associated with Duration of Hospitalization & Complications? , 2010, Obstetrics and gynecology international.
[17] A. Lozniewski,et al. Metronidazole Resistance in Prevotella spp. and Description of a New nim Gene in Prevotella baroniae , 2009, Antimicrobial Agents and Chemotherapy.
[18] D. Marriott,et al. Laboratory Diagnostic Techniques for Entamoeba Species , 2007, Clinical Microbiology Reviews.
[19] S. Parija,et al. A novel nested multiplex polymerase chain reaction (PCR) assay for differential detection of Entamoeba histolytica, E. moshkovskii and E. dispar DNA in stool samples , 2007, BMC Microbiology.
[20] R. Haque,et al. Evidence for a Link between Parasite Genotype and Outcome of Infection with Entamoeba histolytica , 2006, Journal of Clinical Microbiology.
[21] J. Paul,et al. Changes in bacterial profile during amebiasis: demonstration of anaerobic bacteria in ALA pus samples. , 2006, The American journal of tropical medicine and hygiene.
[22] D. Houhoula,et al. Dissemination of nim-class genes, encoding nitroimidazole resistance, among different species of Gram-negative anaerobic bacteria isolated in Athens, Greece. , 2006, The Journal of antimicrobial chemotherapy.
[23] C. Clark,et al. Use of PCR Amplification of tRNA Gene-Linked Short Tandem Repeats for Genotyping Entamoeba histolytica , 2005, Journal of Clinical Microbiology.
[24] Sonja Löfmark,et al. Inducible Metronidazole Resistance and nim Genes in Clinical Bacteroidesfragilis Group Isolates , 2005, Antimicrobial Agents and Chemotherapy.
[25] Mingli,et al. Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma , 2005 .
[26] Y. Chawla,et al. Annals of Clinical Microbiology and Antimicrobials Open Access in Vitro Activity of Antiamoebic Drugs against Clinical Isolates of Entamoeba Histolytica and Entamoeba Dispar , 2022 .
[27] G. Rico,et al. Defective production of reactive oxygen intermediates (ROI) in a patient with recurrent amebic liver abscess. , 2002, The American journal of tropical medicine and hygiene.
[28] P. Morán,et al. Reincidence of amebic liver abscess: a case report. , 2000, Archives of medical research.
[29] S. Trinh,et al. Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp , 1996, Journal of clinical microbiology.
[30] O. Farret,et al. [Hepatic amebiasis: study of 152 cases]. , 1984, Gastroenterologie clinique et biologique.
[31] R. Dietrick. Experience with liver abscess. , 1984, American journal of surgery.
[32] P. Gregory. A refractory case of hepatic amoebiasis. , 1976, Gastroenterology.